TotalMarketCap

Vertex Pharmaceuticals

VRTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$137.653 B

$542.93 -1.11%

Close of 6 Nov 2026

As of 6 Nov 2026, Vertex Pharmaceuticals (VRTX) has a market capitalization of $137.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$12.0B

#366 by revenue

Earnings

$3.95B

#127 by earnings

Shares outstanding

253,537,674

Latest filing cover page

P/E ratio

34.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #8Novo Nordisk A SNVO$178.7B
  2. #9PfizerPFE$170.5B
  3. #10Vertex PharmaceuticalsVRTX$137.7B
  4. #11Bristol Myers SquibbBMY$129.3B
  5. #12SanofiSNY$114.3B

What if Vertex Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$111,371.51

Per share 205× higher

Bitcoin $1.53T

$6,026.12

Per share 11.1× higher

Apple $5.02T

$19,783.18

Per share 36.4× higher

Or at a round number

$200.0B$500.0B$1.00T$2.00T

Where these numbers come from

Share counts and financials for Vertex Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.